Kevin Perrott
Kevin Perrott is Founder and CEO of OpenCures, Treasurer of SENS Research Foundation, co-founder of Oisin Biotechnologies.
After twenty years of growing and managing a successful retail business, Kevin became a cancer survivor and shifted direction to academics to develop methods of curing cancer and other age-related diseases. He graduated from the University of Alberta in 2006 at the age of 43 with a double major in Biology and Chemistry. He then entered the Ph.D. program and after completing two years studying the role of mitochondria in the process of aging in the nematode C. elegans, he shifted focus to the importance of the phenomenon of mammalian cellular senescence and its role in degenerative disease.
Kevin continues to support the advance of aging research as the VP of the American Aging Association, and through his research at the Buck Institute for Research on Aging in the lab of Judith Campisi sponsored by SENS Foundation to mitigate the negative effects of senescent cells.
After twenty years of growing and managing a successful retail business, Kevin became a cancer survivor and shifted direction to academics to develop methods of curing cancer and other age-related diseases. He graduated from the University of Alberta in 2006 at the age of 43 with a double major in Biology and Chemistry. He then entered the Ph.D. program and after completing two years studying the role of mitochondria in the process of aging in the nematode C. elegans, he shifted focus to the importance of the phenomenon of mammalian cellular senescence and its role in degenerative disease.
Kevin continues to support the advance of aging research as the VP of the American Aging Association, and through his research at the Buck Institute for Research on Aging in the lab of Judith Campisi sponsored by SENS Foundation to mitigate the negative effects of senescent cells.